Morning Overview on MSN
NIH is testing a controversial COVID drug as a surprise cancer therapy
A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...
Florida lawmakers and health officials have become fascinated with ivermectin, a controversial anti-parasitic drug, and Republican lawmakers want to make it easier for residents to purchase.
Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition. The world-first study ...
A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in health workers and others closely exposed to ...
A widely used diabetes medication may have more medical uses than doctors first thought as scientists discover it may be able to prevent long covid, but there’s a catch. It needs to be taken early in ...
Scientists have potentially discovered a new use for the common type 2 diabetes drug ...
Amidst a resurgence of COVID-19 cases across the United States, pharmaceutical company Gilead Sciences, Inc. has announced a voluntary recall of its antiviral drug Veklury, commonly known as ...
We are living in an epidemic of chronic disease, with a growing number of pesticides, chemicals and food additives implicated in the declining health of Americans. Since 2019, another factor has been ...
It wasn’t that long ago that people considered Moderna and Pfizer to be saviors. Their work during the COVID-19 pandemic brought on an unusual outpouring of support and goodwill toward the ...
Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results